Ralliant Corporation $RAL Stock Holdings Decreased by DNB Asset Management AS

DNB Asset Management AS lessened its stake in Ralliant Corporation (NYSE:RAL) by 57.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,074 shares of the company’s stock after selling 19,098 shares during the quarter. DNB Asset Management AS’s holdings in Ralliant were worth $615,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Westfuller Advisors LLC acquired a new stake in Ralliant during the third quarter valued at approximately $26,000. Manchester Capital Management LLC acquired a new position in shares of Ralliant in the 2nd quarter worth approximately $29,000. UMB Bank n.a. bought a new stake in shares of Ralliant in the 3rd quarter valued at approximately $29,000. Webster Bank N. A. acquired a new stake in shares of Ralliant during the 3rd quarter valued at approximately $31,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Ralliant during the third quarter worth $34,000.

Ralliant Price Performance

NYSE RAL opened at $47.01 on Thursday. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. The stock has a market cap of $5.25 billion and a price-to-earnings ratio of 23.98. The company has a 50-day moving average price of $49.18 and a two-hundred day moving average price of $46.63.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The firm’s revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s dividend payout ratio is presently 10.20%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on RAL. Truist Financial decreased their price objective on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Morgan Stanley restated an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research report on Friday, February 6th. Oppenheimer lowered their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Weiss Ratings cut shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Finally, Royal Bank Of Canada decreased their target price on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research note on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $50.50.

Insider Activity at Ralliant

In related news, SVP Amir A. Kazmi purchased 2,545 shares of Ralliant stock in a transaction dated Friday, February 6th. The stock was bought at an average cost of $39.27 per share, with a total value of $99,942.15. Following the purchase, the senior vice president owned 39,699 shares in the company, valued at approximately $1,558,979.73. The trade was a 6.85% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kate Mitchell acquired 2,350 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was bought at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the acquisition, the director directly owned 8,411 shares of the company’s stock, valued at approximately $357,299.28. This represents a 38.77% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired 8,145 shares of company stock valued at $332,233 in the last ninety days.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.